CryoLife Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Piper Jaffray Remains Bullish on CryoLife (CRY) Following 2Q Report
July 26, 2016 7:54 AM EDTPiper Jaffray reiterated an Overweight rating and $16.00 price target on CryoLife (NYSE: CRY) following the company's 2Q earnings report. CRY reported revenue of $47.1M, driven by recently acquired On-X, improvements to the vascular tissue business, and strong BioGlue sales. Adjusted cash EPS of $0.13 beat the consensus of $0.07.... More
CryoLife (CRY) Reports Q2 EPS of $0.07
July 25, 2016 5:36 PM EDTCryoLife (NYSE: CRY) reported Q2 EPS of $0.07, versus ($0.02) reported last year. Revenue for the quarter came in at $47.1 million, versus $35.5 million reported last year.
GUIDANCE:
CryoLife sees Q3 2016 EPS of $0.32-$0.32, versus prior guidance of $0.29-$0.32. CryoLife sees Q3 2016... More
